Variant NM_000492.4:c.2421A>G
Name | NM_000492.4:c.2421A>G | ||||
Protein name | NP_000483.3:p.(Ile807Met) | ||||
Genomic name (hg19) | chr7:g.117232642A>G UCSC | ||||
#Exon/intron | exon 14 | ||||
Legacy Name | I807M ; 2553A/G | ||||
Class | disease-causing | ||||
Subclass | CFTR-RD-causing | ||||
complex allele in 22.22% of patients associated with WT sequence |
AGGCAAACTTGACTGAACTGGATAT A TATTCAAGAAGGTTATCTCAAGAAA |
Mutant sequence |
AGGCAAACTTGACTGAACTGGATAT G TATTCAAGAAGGTTATCTCAAGAAA |
|
dbSNP rs1800103 |
Reference | PMID | Splicing | mRNA level | Maturation | Localization | Channel fonction (Cl-) | Bicarbonate |
Vankeerberghen et al, 1998 | 9736778 | ✓ | ✓ |
« ✓ » indicates the type of analysis performed and not the results
Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
IVA | yes | no | yes | no |
TEZ-IVA | yes | no | yes | no |
ELX-TEZ-IVA | yes | no | yes | no |
clinical and functional data are provided by Vertex
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 9 |
---|---|
Asymptomatic compound heterozygote | 2 |
CFTR-RD | 7
|
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CBAVD | 927 | heterozygote | CFTR-RD-causing - Cis CF-causing - Trans |
CBAVD | 4247 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 4248 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Asymptomatic compound heterozygote | 932 | heterozygote | CFTR-RD-causing - Cis CF-causing - Trans |
Asymptomatic compound heterozygote | 5133 | heterozygote | VUS3- Undef |
Pancreatitis | 1632 | heterozygote | CF-causing- Undef |
Pancreatitis | 2185 | heterozygote | |
Pancreatitis | 2252 | heterozygote | CF-causing- Undef |
Other | 4587 | heterozygote |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|